Pump the brakes: identifying neurobiological targets to enhance inhibitory control in drug addiction

Affiliations

¹ Icahn School of Medicine at Mount Sinai, New York, NY, USA.
² Icahn School of Medicine at Mount Sinai, New York, NY, USA. rita.goldstein@mssm.edu.

Ahmet O Ceceli et al. Neuropsychopharmacology. 2024 Nov.

. 2024 Nov;50(1):330-331.

doi: 10.1038/s41386-024-01928-w.

¹ Icahn School of Medicine at Mount Sinai, New York, NY, USA.
² Icahn School of Medicine at Mount Sinai, New York, NY, USA. rita.goldstein@mssm.edu.

Erratum in

Correction: Neuropsychopharmacology Volume 50 Issue 1.
[No authors listed] [No authors listed] Neuropsychopharmacology. 2025 May;50(6):1019-1020. doi: 10.1038/s41386-025-02087-2. Neuropsychopharmacology. 2025. PMID: 40108440 Free PMC article. No abstract available.

No abstract available

The authors declare no competing interests.

1. Garavan H, Potter AS, Brennan KL, Foxe JJ. Neural bases of addiction-related impairments in response inhibition. The Wiley Handbook on the Cognitive Neuroscience of Addiction. John Wiley & Sons, Ltd; 2015. p. 29–54.
1. Menon V, D’Esposito M. The role of PFC networks in cognitive control and executive function. Neuropsychopharmacol. 2022;47:90–103. - PMC - PubMed
1. Ceceli AO, Parvaz MA, King S, Schafer M, Malaker P, Sharma A, et al. Altered prefrontal signaling during inhibitory control in a salient drug context in cocaine use disorder. Cereb Cortex. 2022;33:597–611. - PMC - PubMed
1. Ceceli AO, King S, McClain N, Alia-Klein N, Goldstein RZ. The neural signature of impaired inhibitory control in individuals with heroin use disorder. J Neurosci. 2022;43:173–82. - PMC - PubMed
1. Ceceli AO, Huang Y, Gaudreault P-O, McClain NE, King SG, Kronberg G, et al. Recovery of anterior prefrontal cortex inhibitory control after 15 weeks of inpatient treatment in heroin use disorder. Nat Mental Health. 2024;2:694–702.